Unknown

mm: Friedman
Sent: Wednesday, October 23'. 1996 3:50 PM
To: AIfOnso
Subject: Re[2]: Phase IV OxyComin Team - Minutes

when we get the report, have someone check the before and after calls
to these docs.

Reply Separator
Subject: Re: Phase Iv OxyContin Team Minutes
Author: Alfonso at NORWALK
Date: 10/23/96 2:07 PM

 

 

interesting comments from Dr. Richard. I also wonder if there was a
bias in the form of reprEBentathES increasing calls to the selected
physicians. Would we get the same ROI in as a result of the
representatives increasing the call rate to this selected group,
regardless of dinners? I don't have the list . therefore I don't know
if there was a selected preference towards this group in the part of
the reps. It?s reasonable that these core doctors were already
receiving special attention which would have generated an increase in
Rxs. If this is the case the cost of the dinners would unnecessarily
increase the cost per RX. .

Forward Header
Wed: Re: Phase IV OxyContin rream Minutes
Author: Dr'Richerd Sackler at NORWALK
Date: l0/23/96 11:04 AM

 

 

Michael.
The oxyminl2 said:

"Results showed the following: physicians who attended the dinner
programs or the weekend meetings wrote more than double the number
of new for OxyContin compared to the control group, and this
was sustained over the 3?month post?meeting evaluation period.
Weekend meetings had the greatest impact, increasing new
prescriptions for OxyContln by a factor between 2.16 and 2.62.
These results will be presented in more detail at a later date."

This is very encouraging, although I must allow that a porportion
or a without the associated absolute numbers is inherently
meaningless. Was the number of increased Rx's commercially
significant? If so, what would the cost per increased Rx be
assuming that the absolute difference persisted?

When will a more complete report be available?

Reply Separator
Subject: Phase IV OxyContin Team Minutes?
Author: Linda Harrison at Norwalk2

Date: 10~l7~96 3:45 PM

 

 

 

9 Attached are the Phase IV OxyContin Team Meeting Minutes.
1
7000132742

?1

 

 

 


CONFIDENTIAL SUBJECT TO PROTECTIVE ORDER
IN COMMONWEALTH OF KENTUCKY, EX REL. JACK CONWAY, ATTORNEY GENERAL V, PURDUE
PHARMA L.P., ET AL., CIVIL ACTION NO. (PIKE COUNTY CIRCUIT COURT)